About this Journal Submit a Manuscript Table of Contents

Citations to this Journal [334 citations: 201–300 of 317 articles]

Articles published in Prostate Cancer have been cited 334 times. The following is a list of the 317 articles that have cited the articles published in Prostate Cancer.

  • Guillaume Ploussard, and Pierre Mongiat-Artus, “Triptorelin in the management of prostate cancer,” Future Oncology, vol. 9, no. 1, pp. 93–102, 2013. View at Publisher · View at Google Scholar
  • Michael Blaise Cook, Zhaoming Wang, Edward D. Yeboah, Yao Tettey, Richard B. Biritwum, Andrew A. Adjei, Evelyn Tay, Ann Truelove, Shelley Niwa, Charles C. Chung, Annand P. Chokkalingam, Lisa W. Chu, Meredith Yeager, Amy Hutchinson, Kai Yu, Kristin A. Rand, Christopher A. Haiman, Robert N. Hoover, Ann W. Hsing, and Stephen J. Chanock, “A genome-wide association study of prostate cancer in West African men,” Human Genetics, 2013. View at Publisher · View at Google Scholar
  • Julie K. Bassett, Gianluca Severi, Allison M. Hodge, Robert J. MacInnis, Robert A. Gibson, John L. Hopper, Dallas R. English, and Graham G. Giles, “Plasma phospholipid fatty acids, dietary fatty acids and prostate cancer risk,” International Journal of Cancer, 2013. View at Publisher · View at Google Scholar
  • Zaki Shaikhibrahim, Roopika Menon, Martin Braun, Anne Offermann, Angela Queisser, Diana Boehm, Wenzel Vogel, Kerstin Rüenauver, Christian Ruiz, Tobias Zellweger, Maria Svensson, Ove Andren, Glen Kristiansen, Nicolas Wernert, Lukas Bubendorf, Jutta Kirfel, Saskia Biskup, and Sven Perner, “ MED15 , encoding a subunit of the mediator complex, is overexpressed at high frequency in castration-resistant prostate cancer ,” International Journal of Cancer, 2013. View at Publisher · View at Google Scholar
  • Priya Bhosale, Aparna Balachandran, Raghu Vikram, Chitra Viswanathan, Homer Macapinlac, Eric Rohren, and Ramanujan Prativadi, “What Is the Clinical Significance of FDG Unexpected Uptake in the Prostate in Patients Undergoing PET/CT for Other Malignancies?,” International Journal of Molecular Imaging, vol. 2013, pp. 1–6, 2013. View at Publisher · View at Google Scholar
  • Sakthivel Muniyan, Nagendra Chaturvedi, Jennifer Dwyer, Chad LaGrange, William Chaney, and Ming-Fong Lin, “Human Prostatic Acid Phosphatase: Structure, Function and Regulation,” International Journal of Molecular Sciences, vol. 14, no. 5, pp. 10438–10464, 2013. View at Publisher · View at Google Scholar
  • Colin Cooper, Jaume Reventos, Jeremy Clark, Melania Montes, Eva Colas, Jacques Planas, Andreas Doll, Marta Garcia, Tamara Sequeiros, Marta Llaurado, Ines de Torres, Marina Rigau, Juan Morote, and Mireia Olivan, “The Present and Future of Prostate Cancer Urine Biomarkers,” International Journal Of Molecular Sciences, vol. 14, no. 6, pp. 12620–12649, 2013. View at Publisher · View at Google Scholar
  • James Farrell, Gyorgy Petrovics, David G. McLeod, and Shiv Srivastava, “Genetic and Molecular Differences in Prostate Carcinogenesis between African American and Caucasian American Men,” International Journal of Molecular Sciences, vol. 14, no. 8, pp. 15510–15531, 2013. View at Publisher · View at Google Scholar
  • Godwin O. Ifere, Renee Desmond, Wendy Demark-Wahnefried, and Tim R. Nagy, “Apolipoprotein E gene polymorphism influences aggressive behavior in prostate cancer cells by deregulating cholesterol homeostasis,” International Journal of Oncology, vol. 43, no. 4, pp. 1002–1010, 2013. View at Publisher · View at Google Scholar
  • D. Le Broc-Ryckewaert, R. Carpentier, E. Lipka, S. Daher, C. Vaccher, D. Betbeder, and C. Furman, “Development of innovative paclitaxel-loaded small PLGA nanoparticles: Study of their antiproliferative activity and their molecular interactions on prostatic cancer cells,” International Journal of Pharmaceutics, 2013. View at Publisher · View at Google Scholar
  • Takahiro Kimura, Masahito Kido, Kenta Miki, Toshihiro Yamamoto, Hiroshi Sasaki, Hidetoshi Kuruma, Norihiro Hayashi, Hiroyuki Takahashi, Manabu Aoki, and Shin Egawa, “Mid-term outcome of permanent prostate iodine-125 brachytherapy in Japanese patients,” International Journal of Urology, 2013. View at Publisher · View at Google Scholar
  • Anup Vora, Tim Large, Jenny Aronica, Sherod Haynes, Andrew Harbin, Daniel Marchalik, Hanaa Nissim, John Lynch, Gaurav Bandi, Kevin McGeagh, Keith Kowalczyk, Reza Ghasemian, Krishnan Venkatesan, Mohan Verghese, and Jonathan Hwang, “Predictors of Gleason score upgrading in a large African-American population,” International Urology and Nephrology, vol. 45, no. 5, pp. 1257–1262, 2013. View at Publisher · View at Google Scholar
  • S. Voros, A. Moreau-Gaudry, B. Tamadazte, G. Custillon, R. Heus, M.-P. Montmasson, F. Giroud, O. Gaiffe, C. Pieralli, G. Fiard, J.-A. Long, J.-L. Descotes, C. Vidal, A. Nguyen-Dinh, and P. Cinquin, “Devices and systems targeted towards augmented robotic radical prostatectomy,” Irbm, vol. 34, no. 2, pp. 139–146, 2013. View at Publisher · View at Google Scholar
  • Cheng Liu, Chang Wang, Kun Wang, Li Liu, Qi Shen, Keqiang Yan, Xiaoqing Sun, Jie Chen, Jikai Liu, Hongbo Ren, Hainan Liu, Zhonghua Xu, Sanyuan Hu, Dawei Xu, and Yidong Fan, “SMYD3 as an Oncogenic Driver in Prostate Cancer by Stimulation of Androgen Receptor Transcription,” Jnci-Journal of The National Cancer Institute, vol. 105, no. 22, pp. 1719–1728, 2013. View at Publisher · View at Google Scholar
  • Ricarda Locher, Paola A. Erba, Burkhard Hirsch, Emilio Bombardieri, Leonardo Giovannoni, Dario Neri, Horst Dürkop, and Hans D. Menssen, “Abundant in vitro expression of the oncofetal ED-B-containing fibronectin translates into selective pharmacodelivery of 131I-L19SIP in a prostate cancer patient,” Journal of Cancer Research and Clinical Oncology, 2013. View at Publisher · View at Google Scholar
  • Matthew R. Cooperberg, Jeffry P. Simko, Janet E. Cowan, Julia E. Reid, Azita Djalilvand, Satish Bhatnagar, Alexander Gutin, Jerry S. Lanchbury, Gregory P. Swanson, Steven Stone, and Peter R. Carroll, “Validation of a Cell-Cycle Progression Gene Panel to Improve Risk Stratification in a Contemporary Prostatectomy Cohort,” Journal Of Clinical Oncology, vol. 31, no. 11, pp. 1428–1434, 2013. View at Publisher · View at Google Scholar
  • Debasish Sundi, Ashley E. Ross, Elizabeth B. Humphreys, Misop Han, Alan W. Partin, H. Ballentine Carter, and Edward M. Schaeffer, “African American Men With Very Low-Risk Prostate Cancer Exhibit Adverse Oncologic Outcomes After Radical Prostatectomy: Should Active Surveillance Still Be an Option for Them?,” Journal of Clinical Oncology, vol. 31, no. 24, pp. 2991–2997, 2013. View at Publisher · View at Google Scholar
  • Daniel A Barocas, Vivien Chen, Matthew Cooperberg, Michael Goodman, John J Graff, Sheldon Greenfield, Ann Hamilton, Karen Hoffman, Sherrie Kaplan, Tatsuki Koyama, Alicia Morgans, Lisa E Paddock, Sharon Phillips, Matthew J Resnick, Antoinette Stroup, Xiao Cheng Wu, and David F Penson, “Using a population-based observational cohort study to address difficult comparative effectiveness research questions: the CEASAR study,” Journal of Comparative Effectiveness Research, vol. 2, no. 4, pp. 445–460, 2013. View at Publisher · View at Google Scholar
  • Huai-Ching Tai, Ming-Kuen Lai, Chao-Yuan Huang, Shuo-Meng Wang, Kuo-How Huang, Chung-Hsin Chen, Shiu-Dong Chung, Shih-Chieh Jeff Chueh, Hong-Jeng Yu, and Yeong-Shiau Pu, “Laparoscopic Radical Prostatectomy Monotherapy, a More Aggressive Yet Less Invasive Option, Is Oncologically Effective in Selected Men with High-Risk Prostate Cancer Having Only One D'Amico Risk Factor: Experience from an Asian Tertiary Referral Center,” Journal of Endourology, pp. 131017062937009, 2013. View at Publisher · View at Google Scholar
  • Zi-lian Cui, Guan-bin Li, Yu-zhu Xiang, Qing-hua Xia, Xun-bo Jin, Shao-bo Jiang, Yong Zhao, and Hui Xiong, “The association between metabolic syndrome and the risk of prostate cancer, high-grade prostate cancer, advanced prostate cancer, prostate cancer-specific mortality and biochemical recurrence,” Journal Of Experimental & Clinical Cancer Research, vol. 32, 2013. View at Publisher · View at Google Scholar
  • Elizabeth Handorf, Nicole Crumpler, Laura Gross, and Veda N. Giri, “Prevalence of the HOXB13 G84E Mutation Among Unaffected Men with a Family History of Prostate Cancer,” Journal of Genetic Counseling, 2013. View at Publisher · View at Google Scholar
  • Changsheng Xing, Xiaoying Fu, Xiaodong Sun, and Jin-Tang Dong, “Lack of an Additive Effect between the Deletions of Klf5 and Nkx3-1 in Mouse Prostatic Tumorigenesis,” Journal of Genetics and Genomics, 2013. View at Publisher · View at Google Scholar
  • Jennifer L. Quon, James B. Yu, Pamela R. Soulos, and Cary P. Gross, “The relation between age and androgen deprivation therapy use among men in the Medicare population receiving radiation therapy for prostate cancer,” Journal of Geriatric Oncology, vol. 4, no. 1, pp. 9–18, 2013. View at Publisher · View at Google Scholar
  • Joo Yong Lee, Richilda Red Diaz, Kang Su Cho, and Young Deuk Choi, “Meta-analysis of Transperitoneal Versus Extraperitoneal Robot-Assisted Radical Prostatectomy for Prostate Cancer,” Journal of Laparoendoscopic & Advanced Surgical Techniques, pp. 131001073810004, 2013. View at Publisher · View at Google Scholar
  • Puranik Purushottamachar, Abhijit M. Godbole, Lalji K. Gediya, Marlena S. Martin, Tadas S. Vasaitis, Andrew K. Kwegyir-Afful, Senthilmurugan Ramalingam, Zeynep Ates-Alagoz, and Vincent C. O. Njar, “Systematic Structure Modifications of Multitarget Prostate Cancer Drug Candidate Galeterone To Produce Novel Androgen Receptor Down-Regulating Agents as an Approach to Treatment of Advanced Prostate Cancer,” Journal of Medicinal Chemistry, pp. 130607162246006, 2013. View at Publisher · View at Google Scholar
  • Zhi Liu, Yinfu Xu, Ben Sang, Jianbing Mo, Rutong Yu, Xiuping Zhou, Jinming Qian, Lei Hua, and Qiong Shi, “Geranylgeranyltransferase I Promotes Human Glioma Cell Growth through Rac1 Membrane Association and Activation,” Journal Of Molecular Neuroscience, vol. 49, no. 1, pp. 130–139, 2013. View at Publisher · View at Google Scholar
  • Renato A. Valdes-Olmos, Nynke S. van den Berg, and Henk G. van der Poel, “Sentinel Lymph Node Biopsy for Prostate Cancer: A Hybrid Approach,” Journal Of Nuclear Medicine, vol. 54, no. 4, pp. 493–496, 2013. View at Publisher · View at Google Scholar
  • Katsumi Shigemura, Nozomu Yamanaka, and Masuo Yamashita, “Can Diffusion-Weighted Magnetic Resonance Imaging Predict a High Gleason Score of Prostate Cancer?,” Korean Journal of Urology, vol. 54, no. 4, pp. 234, 2013. View at Publisher · View at Google Scholar
  • James J Cody, Angel A Rivera, Gray R Lyons, Sherry W Yang, Minghui Wang, Jason W Ashley, Sreelatha Meleth, Xu Feng, Gene P Siegal, and Joanne T Douglas, “Expression of osteoprotegerin from a replicating adenovirus inhibits the progression of prostate cancer bone metastases in a murine model,” Laboratory Investigation, vol. 93, no. 3, pp. 268–278, 2013. View at Publisher · View at Google Scholar
  • Oscar R. Brouwer, A. Noe, Renato A. Valdés Olmos, and Axel Bex, “Lymphatic Drainage from Renal Cell Carcinoma along the Thoracic Duct Visualized with SPECT/CT,” Lymphatic Research and Biology, vol. 11, no. 4, pp. 233–238, 2013. View at Publisher · View at Google Scholar
  • Paul Posadzki, Myeong Soo Lee, Igho Onakpoya, Hye Won Lee, Byong Seob Ko, and Edzard Ernst, “Dietary supplements and prostate cancer: a systematic review of double-blind, placebo-controlled randomised clinical trials,” Maturitas, vol. 75, no. 2, pp. 125–130, 2013. View at Publisher · View at Google Scholar
  • Raúl Baena Ruiz, and Pedro Salinas Hernández, “Diet and Cancer: Risk factors and epidemiological evidence,” Maturitas, 2013. View at Publisher · View at Google Scholar
  • Xue Rui, Ma Shengli, Jia Zhankui, Pi Guofu, and Yang Jinjian, “HMGB1: A potential target for treatment of benign prostatic hyperplasia,” Medical Hypotheses, 2013. View at Publisher · View at Google Scholar
  • Tobias Pommer, Marianne Falk, Per Rugaard Poulsen, Paul J. Keall, Ricky T. O’Brien, and Per Munck af Rosenschöld, “The impact of leaf width and plan complexity on DMLC tracking of prostate intensity modulated arc therapy,” Medical Physics, vol. 40, no. 11, pp. 111717, 2013. View at Publisher · View at Google Scholar
  • S. Belikov, C. Öberg, T. Jääskeläinen, V. Rahkama, J.J. Palvimo, and Ö. Wrange, “FoxA1 corrupts the antiandrogenic effect of bicalutamide but only weakly attenuates the effect of MDV3100 (Enzalutamide™),” Molecular and Cellular Endocrinology, vol. 365, no. 1, pp. 95–107, 2013. View at Publisher · View at Google Scholar
  • Sara Pignatta, Chiara Arienti, Wainer Zoli, Marzia Di Donato, Gabriella Castoria, Elisa Gabucci, Valentina Casadio, Mirella Falconi, Ugo De Giorgi, Rosella Silvestrini, and Anna Tesei, “Prolonged exposure to (R)-bicalutamide generates a LNCaP subclone with alteration of mitochondrial genome,” Molecular and Cellular Endocrinology, 2013. View at Publisher · View at Google Scholar
  • Trinath P. Das, Suman Suman, and Chendil Damodaran, “Reactive oxygen species generation inhibits epithelial-mesenchymal transition and promotes growth arrest in prostate cancer cells,” Molecular Carcinogenesis, 2013. View at Publisher · View at Google Scholar
  • Isaac J. Powell, and Aliccia Bollig-Fischer, “Minireview: The Molecular and Genomic Basis for Prostate Cancer Health Disparities,” Molecular Endocrinology, vol. 27, no. 6, pp. 879–891, 2013. View at Publisher · View at Google Scholar
  • Paloma Olvera-Caltzontzin, Guadalupe Delgado, and Carmen Aceves, “Iodine Uptake and Prostate Cancer in the TRAMP Mouse Model,” Molecular Medicine, vol. 19, pp. 409–416, 2013. View at Publisher · View at Google Scholar
  • Kimberley Carter, “Advances in prostate cancer treatment,” Nature Reviews Drug Discovery, vol. 12, no. 11, pp. 823–824, 2013. View at Publisher · View at Google Scholar
  • Ashwin N. Sridhar, Archie Hughes-Hallett, Erik K. Mayer, Philip J. Pratt, Philip J. Edwards, Guang-Zhong Yang, Ara W. Darzi, and Justin A. Vale, “Image-guided robotic interventions for prostate cancer,” Nature Reviews Urology, 2013. View at Publisher · View at Google Scholar
  • Nicholas G. Zaorsky, Amy S. Harrison, Edouard J. Trabulsi, Leonard G. Gomella, Timothy N. Showalter, Mark D. Hurwitz, Adam P. Dicker, and Robert B. Den, “Evolution of advanced technologies in prostate cancer radiotherapy,” Nature Reviews Urology, 2013. View at Publisher · View at Google Scholar
  • K. Franke, M. Baur, L. Daum, M. Vaegler, K.-D. Sievert, and B. Schlosshauer, “Prostate carcinoma cell growth-inhibiting hydrogel supports axonal regeneration in vitro,” Neuroscience Letters, vol. 541, pp. 248–252, 2013. View at Publisher · View at Google Scholar
  • L. Y. Aydin, A. K. Uzunlar, K. Cam, A. Tekin, H. Erdem, U. Yildirim, C. Sahiner, M. A. Kayikci, M. Oktay, and H. Ankarali, “Relationship among expression of basic-fibroblast growth factor, MTDH/Astrocyte elevated gene-1, adenomatous polyposis coli, matrix metalloproteinase 9,and COX-2 markers with prognostic factors in prostate carcinomas,” Nigerian Journal Of Clinical Practice, vol. 16, no. 4, pp. 418–423, 2013. View at Publisher · View at Google Scholar
  • Georgia Lenihan-Geels, Karen S. Bishop, and Lynnette R. Ferguson, “Alternative Sources of Omega-3 Fats: Can We Find a Sustainable Substitute for Fish?,” Nutrients, vol. 5, no. 4, pp. 1301–1315, 2013. View at Publisher · View at Google Scholar
  • Hueseyin Sirma, Margarethe Broemel, Laura Stumm, Tina Tsourlakis, Stefan Steurer, Pierre Tennstedt, Georg Salomon, Uwe Michl, Alexander Haese, Ronald Simon, Guido Sauter, Thorsten Schlomm, and Sarah Minner, “Loss of CDKN1B/p27Kip1 expression is associated with ERG fusion-negative prostate cancer, but is unrelated to patient prognosis,” Oncology Letters, vol. 6, no. 5, pp. 1245–1252, 2013. View at Publisher · View at Google Scholar
  • Joanne M. Harrington, Dawn C. Schwenke, Dana R. Epstein, and Donald E. Bailey, “Androgen-Deprivation Therapy and Metabolic Syndrome in Men With Prostate Cancer,” Oncology Nursing Forum, vol. 41, no. 1, pp. 21–29, 2013. View at Publisher · View at Google Scholar
  • Hifzur Rahman Siddique, Aijaz Parray, Weixiong Zhong, R. Jeffery Karnes, Eric J. Bergstralh, Shahriar Koochekpour, Johng S. Rhim, Badrinath R. Konety, and Mohammad Saleem, “BMI1, Stem Cell Factor Acting as Novel Serum-biomarker for Caucasian and African-American Prostate Cancer,” Plos One, vol. 8, no. 1, 2013. View at Publisher · View at Google Scholar
  • Maja Narlik-Grassow, Carmen Blanco-Aparicio, Yolanda Cecilia, Marco Perez, Sandra Munoz-Galvan, Marta Canamero, and Amancio Carnero, “Conditional Transgenic Expression of PIM1 Kinase in Prostate Induces Inflammation-Dependent Neoplasia,” Plos One, vol. 8, no. 4, 2013. View at Publisher · View at Google Scholar
  • Hasan Mukhtar, Aijaz Parray, R. Jeffery Karnes, Yibin Deng, Badrinath R. Konety, Mohammad Saleem, Hifzur Rahman Siddique, Rohinton S. Tarapore, and Lei Wang, “BMI1 Polycomb Group Protein Acts as a Master Switch for Growth and Death of Tumor Cells: Regulates TCF4-Transcriptional Factor-Induced BCL2 Signaling,” Plos One, vol. 8, no. 5, 2013. View at Publisher · View at Google Scholar
  • Elisabeth Gustafson-Wagner, and Christopher S. Stipp, “The CD9/CD81 Tetraspanin Complex and Tetraspanin CD151 Regulate alpha 3 beta 1 Integrin-Dependent Tumor Cell Behaviors by Overlapping but Distinct Mechanisms,” Plos One, vol. 8, no. 4, 2013. View at Publisher · View at Google Scholar
  • Changsheng Xing, Xiaodong Sun, Peng Guo, Mei Li, Xiaoying Fu, and Jin-Tang Dong, “Different Expression Patterns and Functions of Acetylated and Unacetylated Klf5 in the Proliferation and Differentiation of Prostatic Epithelial Cells,” Plos One, vol. 8, no. 6, 2013. View at Publisher · View at Google Scholar
  • Peter H. Gann, Mahesh Mohnani, Erika Enk Rueter, Anup Amatya, Ryan Deaton, Yirong Yang, and Viju Ananthanarayanan, “Development of a Nuclear Morphometric Signature for Prostate Cancer Risk in Negative Biopsies,” Plos One, vol. 8, no. 7, 2013. View at Publisher · View at Google Scholar
  • Susan E. Erdman, Bruce H. Horwitz, Tatiana Levkovich, Chung-Wei Lee, Zhongming Ge, Theofilos Poutahidis, Kelsey Cappelle, Michael Doulberis, and James G. Fox, “Pathogenic Intestinal Bacteria Enhance Prostate Cancer Development via Systemic Activation of Immune Cells in Mice,” Plos One, vol. 8, no. 8, 2013. View at Publisher · View at Google Scholar
  • N.G. Agoua, E. Vian, M. Dumoulin, and P. Blanchet, “Résultats de la radiothérapie de rattrapage pour récidive biologique après prostatectomie radicale dans la population africaine-caribéene de la Guadeloupe,” Progrès en Urologie, vol. 23, no. 2, pp. 128–136, 2013. View at Publisher · View at Google Scholar
  • H. Haddad, N. Sellal, and Z. Bourhaleb, “Carcinome à cellules en bague à chaton primitif de la prostate : une entité rare,” Progrès en Urologie, 2013. View at Publisher · View at Google Scholar
  • L Hughes, K Ruth, T R Rebbeck, and V N Giri, “Genetic variation in IL-16 miRNA target site and time to prostate cancer diagnosis in African-American men,” Prostate Cancer and Prostatic Disease, 2013. View at Publisher · View at Google Scholar
  • Georgios Gakis, Arnulf Stenzl, and Markus Renninger, “Do we use the right criteria for determining the clinical significance of incidental prostate cancer at radical cystoprostatectomy?,” Scandinavian Journal of Urology, vol. 47, no. 5, pp. 358–362, 2013. View at Publisher · View at Google Scholar
  • Bjorn Brennhovd, Karol Axcrona, Sophie D. Fossa, Karl-Erik Giercksky, Ljiljana Vlatkovic, and Alv A. Dahl, “Robot-assisted radical prostatectomy of clinical high-risk patients with prostate cancer: A controlled study of operative and short-term postoperative events,” Scandinavian Journal of Urology, vol. 47, no. 6, pp. 449–455, 2013. View at Publisher · View at Google Scholar
  • Marina Ivanovic, Xinchun Zhou, Michael P. Gailey, Zhi He, Alan D. Penman, Steven J. Dias, Anait S. Levenson, Swati Dhar, Liangfen Zhang, and Srinivasan Vijayakumar, “Nuclear MTA1 overexpression is associated with aggressive prostate cancer, recurrence and metastasis in African Americans,” Scientific Reports, vol. 3, 2013. View at Publisher · View at Google Scholar
  • Michael Rehman, and Luca Tamagnone, “Semaphorins in cancer: Biological mechanisms and therapeutic approaches,” Seminars in Cell & Developmental Biology, vol. 24, no. 3, pp. 179–189, 2013. View at Publisher · View at Google Scholar
  • Jean Hoffman-Censits, and Maofu Fu, “Chemotherapy and Targeted Therapies: Are We Making Progress in Castrate-Resistant Prostate Cancer?,” Seminars in Oncology, vol. 40, no. 3, pp. 361–374, 2013. View at Publisher · View at Google Scholar
  • Carlos E. Rodriguez-Diaz, “Sexual Health Promotion and the Attention to the Social Determinants of Health in the Caribbean,” Sexuality Research and Social Policy, 2013. View at Publisher · View at Google Scholar
  • T. Langsenlehner, C. Döller, P. Winkler, G. Gallé, and K.S. Kapp, “Impact of inter- and intrafraction deviations and residual set-up errors on PTV margins,” Strahlentherapie und Onkologie, vol. 189, no. 4, pp. 321–328, 2013. View at Publisher · View at Google Scholar
  • M. Guckenberger, I. Lawrenz, and M. Flentje, “Moderately hypofractionated radiotherapy for localized prostate cancer,” Strahlentherapie und Onkologie, 2013. View at Publisher · View at Google Scholar
  • Gurdarshan S. Sandhu, Kenneth G. Nepple, Youssef S. Tanagho, and Gerald L. Andriole, “Laparoscopic Prostatectomy for Prostate Cancer,” Surgical Oncology Clinics of North America, vol. 22, no. 1, pp. 125–141, 2013. View at Publisher · View at Google Scholar
  • Natasa Tesic, and Maja Cemazar, “In Vitro Targeted Gene Electrotransfer to Endothelial Cells with Plasmid DNA Containing Human Endothelin-1 Promoter,” The Journal of Membrane Biology, 2013. View at Publisher · View at Google Scholar
  • Roopika Menon, Mario Deng, Kerstin Rüenauver, Angela Queisser, Martin Pfeifer, Anne Offermann, Diana Boehm, Wenzel Vogel, Veit Scheble, Falko Fend, Glen Kristiansen, Nicolas Wernert, Nicole Oberbeckmann, Saskia Biskup, Mark A Rubin, Zaki Shaikhibrahim, and Sven Perner, “ Somatic copy number alterations by whole-exome sequencing implicates YWHAZ and PTK2 in castration-resistant prostate cancer ,” The Journal of Pathology, vol. 231, no. 4, pp. 505–516, 2013. View at Publisher · View at Google Scholar
  • H. Ballentine Carter, Peter C. Albertsen, Michael J. Barry, Ruth Etzioni, Stephen J. Freedland, Kirsten Lynn Greene, Lars Holmberg, Philip Kantoff, Badrinath R. Konety, Mohammad Hassan Murad, David F. Penson, and Anthony L. Zietman, “Early Detection of Prostate Cancer: AUA Guideline,” The Journal of Urology, 2013. View at Publisher · View at Google Scholar
  • Debasish Sundi, Oleksandr N. Kryvenko, H. Ballentine Carter, Ashley E. Ross, Jonathan I. Epstein, and Edward M. Schaeffer, “Pathological Examination of Radical Prostatectomy Specimens in Men with Very Low Risk Disease at Biopsy Reveals Distinct Zonal Distribution of Cancer in Black American Men,” The Journal of Urology, 2013. View at Publisher · View at Google Scholar
  • Minyi He, Yun Liu, Xinjun Deng, Songtao Qi, Xuegang Sun, Gang Liu, Yongguang Liu, Yawei Liu, and Ming Zhao, “Down-regulation of miR-200b-3p by low p73 contributes to the androgen-independence of prostate cancer cells,” The Prostate, 2013. View at Publisher · View at Google Scholar
  • Raymond B. Nagle, Amit M. Algotar, Connie C. Cortez, Katherine Smith, Carol Jones, Ubaradka G. Sathyanarayana, Steven Yun, Janice Riley, Dea Nagy, Ryan Dittamore, Bruce Dalkin, Laura Brosh, and Gary Pestano, “ERG Overexpression and PTEN Status Predict Capsular Penetration in Prostate Carcinoma,” The Prostate, 2013. View at Publisher · View at Google Scholar
  • Roger A. Vaughan, Randi Garcia-Smith, Kristina A. Trujillo, and Marco Bisoffi, “Tumor necrosis factor alpha increases aerobic glycolysis and reduces oxidative metabolism in prostate epithelial cells,” The Prostate, 2013. View at Publisher · View at Google Scholar
  • Ahmet Tefekli, and Murat Tunc, “Future Prospects in the Diagnosis and Management of Localized Prostate Cancer,” The Scientific World Journal, vol. 2013, pp. 1–9, 2013. View at Publisher · View at Google Scholar
  • Yi Zhang, Hao Hu, Lu Song, Lin Cai, Renxiong Wei, and Wei Jin, “Epirubicin-mediated expression of miR-302b is involved in osteosarcoma apoptosis and cell cycle regulation,” Toxicology Letters, 2013. View at Publisher · View at Google Scholar
  • Bao-Sheng Wang, Zhen Liu, Wei-Xue Xu, and Shao-Long Sun, “CYP3A5*3 polymorphism and cancer risk: a meta-analysis and meta-regression,” Tumor Biology, 2013. View at Publisher · View at Google Scholar
  • Yun-Sok Ha, Amirali Salmasi, Michael Karellas, Eric A. Singer, Jeong Hyun Kim, Misop Han, Alan W. Partin, Wun-Jae Kim, Dong Hyeon Lee, and Isaac Yi Kim, “Increased Incidence of Pathologically Nonorgan Confined Prostate Cancer in African-American Men Eligible for Active Surveillance,” Urology, vol. 81, no. 4, pp. 831–836, 2013. View at Publisher · View at Google Scholar
  • Milan Hora, Petr Stransky, Jiri Klecka, Ivan Travnicek, Tomas Uerge, Viktor Eret, Jiri Ferda, Fredrik Petersson, and Ondrej Hes, “Managing urine leakage following laparoscopic radical prostatectomy with active suction of the prevesical space,” Videosurgery And Other Miniinvasive Techniques, vol. 8, no. 1, pp. 49–54, 2013. View at Publisher · View at Google Scholar
  • Mearini Luigi, “High intensity focused ultrasound, liver disease and bridging therapy,” World Journal of Gastroenterology, vol. 19, no. 43, pp. 7494–7499, 2013. View at Publisher · View at Google Scholar
  • Cristina Falavolti, Federico Sergi, Ervin Shehu, and Maurizio Buscarini, “York Mason Procedure to Repair Iatrogenic Rectourinary Fistula: Our Experience,” World Journal of Surgery, 2013. View at Publisher · View at Google Scholar
  • Pierre Colin, Serge Mordon, Pierre Nevoux, Mohammed Feras Marqa, Adil Ouzzane, Philippe Puech, Gregory Bozzini, Bertrand Leroux, Arnauld Villers, and Nacim Betrouni, “Focal Laser Ablation of Prostate Cancer: Definition, Needs, and Future,” Advances in Urology, vol. 2012, pp. 1–10, 2012. View at Publisher · View at Google Scholar
  • Andrew Rundle, Kathryn M. Neckerman, Daniel Sheehan, Michelle Jankowski, Oleksandr N. Kryvenko, Deliang Tang, and Benjamin A. Rybicki, “A prospective study of socioeconomic status, prostate cancer screening and incidence among men at high risk for prostate cancer,” Cancer Causes & Control, vol. 24, no. 2, pp. 297–303, 2012. View at Publisher · View at Google Scholar
  • Jacqueline M. Major, M. Norman Oliver, Chyke A. Doubeni, Albert R. Hollenbeck, Barry I. Graubard, and Rashmi Sinha, “Socioeconomic status, healthcare density, and risk of prostate cancer among African American and Caucasian men in a large prospective study,” Cancer Causes & Control, vol. 23, no. 7, pp. 1185–1191, 2012. View at Publisher · View at Google Scholar
  • Afshin Varzavand, Justin M. Drake, Robert U. Svensson, Mary E. Herndon, Bo Zhou, Michael D. Henry, and Christopher S. Stipp, “Integrin α3β1 regulates tumor cell responses to stromal cells and can function to suppress prostate cancer metastatic colonization,” Clinical & Experimental Metastasis, vol. 30, no. 4, pp. 541–552, 2012. View at Publisher · View at Google Scholar
  • Tobias Lange, Sebastian Ullrich, Imke Mueller, Michael F. Nentwich, Katrin Stuebke, Susanne Feldhaus, Christine Knies, Olaf J. C. Hellwinkel, Robert L. Vessella, Claudia Abramjuk, Mario Anders, Jennifer Schroeder-Schwarz, Thorsten Schlomm, Hartwig Huland, Guido Sauter, and Udo Schumacher, “Human Prostate Cancer in a Clinically Relevant Xenograft Mouse Model: Identification of beta(1,6)-Branched Oligosaccharides as a Marker of Tumor Progression,” Clinical Cancer Research, vol. 18, no. 5, pp. 1364–1373, 2012. View at Publisher · View at Google Scholar
  • Henk G. van der Poel, Oscar R. Brouwer, Nynke S. van den Berg, Tessa Buckle, and Fijs W. B. van Leeuwen, “Reply to Karol Polom, Dawid Murawa, Wojciech Polom's Letter to the Editor re: Henk G. van der Poel, Tessa Buckle, Oscar R. Brouwer, Renato A. Valdes Olmos, Fijs WB van Leeuwen. Intraoperative Laparoscopic Fluorescence Guidance to the Sentinel Lymph Node in Prostate Cancer Patients: Clinical Proof of Concept of an Integrated Functional Imaging Approach Using a Multimodal Tracer. Eur Urol 2011;60:826-33,” European Urology, vol. 61, no. 3, pp. E19–E20, 2012. View at Publisher · View at Google Scholar
  • Alexander C Small, and William K Oh, “Bevacizumab treatment of prostate cancer,” Expert Opinion on Biological Therapy, vol. 12, no. 9, pp. 1241–1249, 2012. View at Publisher · View at Google Scholar
  • David Shapiro, and Basir Tareen, “Current and emerging treatments in the management of castration-resistant prostate cancer,” Expert Review of Anticancer Therapy, vol. 12, no. 7, pp. 951–964, 2012. View at Publisher · View at Google Scholar
  • Sma Rizvi, Bj Allen, Cs Lee, F Bruchertseifer, C Apostolidis, A Morgenstern, and Ra Clarke, “ Orthotopic administration of 213 Bi–bevacizumab inhibits progression of PC3 xenografts in the prostate ,” Immunotherapy, vol. 4, no. 5, pp. 549–554, 2012. View at Publisher · View at Google Scholar
  • Sina Grebhardt, Christian Veltkamp, Philipp Ströbel, and Doris Mayer, “Hypoxia and HIF-1 increase S100A8 and S100A9 expression in prostate cancer,” International Journal of Cancer, vol. 131, no. 12, pp. 2785–2794, 2012. View at Publisher · View at Google Scholar
  • Jennifer J. Salinas, Manasi Shah, Bassent Abdelbary, Jennifer L. Gay, and Ken Sexton, “Application of a Novel Method for Assessing Cumulative Risk Burden by County,” International Journal of Environmental Research and Public Health, vol. 9, no. 12, pp. 1820–1835, 2012. View at Publisher · View at Google Scholar
  • Hideaki Miyake, and Masato Fujisawa, “Prognostic prediction following radical prostatectomy for prostate cancer using conventional as well as molecular biological approaches,” International Journal of Urology, vol. 20, no. 3, pp. 301–311, 2012. View at Publisher · View at Google Scholar
  • Shin Ogita, Sheela Tejwani, Lance Heilbrun, Joseph Fontana, Elisabeth Heath, Stacy Freeman, Daryn Smith, Karen Baranowski, and Ulka Vaishampayan, “Pilot Phase II Trial of Bevacizumab Monotherapy in Nonmetastatic Castrate-Resistant Prostate Cancer,” ISRN Oncology, vol. 2012, pp. 1–7, 2012. View at Publisher · View at Google Scholar
  • G. S. Sandhu, and G. L. Andriole, “Overdiagnosis of Prostate Cancer,” JNCI Monographs, vol. 2012, no. 45, pp. 146–151, 2012. View at Publisher · View at Google Scholar
  • Patricia Ng, Elinor R. Schoenfeld, Anselm Hennis, Suh-Yuh Wu, M. Cristina Leske, and Barbara Nemesure, “Factors Influencing Prostate Cancer Healthcare Practices in Barbados, West Indies,” Journal of Immigrant and Minority Health, vol. 15, no. 3, pp. 653–660, 2012. View at Publisher · View at Google Scholar
  • Barbara Nemesure, Suh-Yuh Wu, Anselm Hennis, and M. Cristina Leske, “Family History of Prostate Cancer in a Black Population,” Journal of Immigrant and Minority Health, vol. 15, no. 6, pp. 1107–1112, 2012. View at Publisher · View at Google Scholar
  • Jiaming Liu, Jin Huang, Yazhou He, Jinnan Liu, Banghua Liao, and Ga Liao, “Genetic variants in the integrin gene predicted microRNA-binding sites were associated with the risk of prostate cancer,” Molecular Carcinogenesis, 2012. View at Publisher · View at Google Scholar
  • Olivier Rouviere, Albert Gelet, Sebastien Crouzet, and Jean-Yves Chapelon, “Prostate focused ultrasound focal therapy-imaging for the future,” Nature Reviews Clinical Oncology, vol. 9, no. 12, pp. 721–727, 2012. View at Publisher · View at Google Scholar
  • Xiaobin Wang, Zhikun Ma, Zheng Xiao, Hui Liu, Zhongling Dou, Xiaoshan Feng, and Haijun Shi, “Chk1 knockdown confers radiosensitization in prostate cancer stem cells,” Oncology Reports, vol. 28, no. 6, pp. 2247–2254, 2012. View at Publisher · View at Google Scholar
  • Alina Wozniak, Rafal Masiak, Michal Szpinda, Celestyna Mila-Kierzenkowska, Bartosz Wozniak, Roman Makarewicz, and Anna Szpinda, “Oxidative Stress Markers in Prostate Cancer Patients after HDR Brachytherapy Combined with External Beam Radiation,” Oxidative Medicine and Cellular Longevity, vol. 2012, pp. 1–5, 2012. View at Publisher · View at Google Scholar